UPDATE: Oppenheimer Raises PT On Globus Medical On Pre-Announced 4Q14 Revenue

By: via Benzinga
In a report published Wednesday, Oppenheimer analyst Steven Lichtman reiterated an Outperform rating on Globus Medical (NYSE: GMED), and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.